BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Amid shifting cryptocurrency market liquidity and increasing institutional oversight in early 2026, Zoomex has announced a ...
Ensysce Biosciences (ENSC) issued its 2025 annual letter to shareholders from CEO Lynn Kirkpatrick, which read in part, “2025 was a year of meaningful execution and strategic advancement for Ensysce.
Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) -- GlobalTech Horizons Asia (GTH-Asia) , in collaboration with JYSigma Business Consultancy , has concluded its 2025 preparation and foundation phase and ...
The MarketWatch News Department was not involved in the creation of this content. Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) -- GlobalTech Horizons Asia (GTH-Asia), in collaboration with JYSigma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results